Latest filing published 23 Feb 2017 for Acadia Pharmaceuticals INC, €255k.
Filing timeline
BuySaleInsider track record
Terrence O. Moore: trading record in brief
Terrence O. Moore appears in our data through filings on Acadia Pharmaceuticals Inc shares, published by SEC (Form 4). Between 14 February 2017 and 21 February 2017, the trades on record add up to 10 filings.
Sales make up the whole of the open-market record (4 sales, €6.2M). The rest of the record consists of 6 option exercises.
The newest entry dates from 23 February 2017: an option exercise of €255k, in Acadia Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Terrence O. Moore
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,856 shares@ US$34.452.6% of flowCommon StockSEC:0001415889-17-000308:0
- 7,856 shares@ US$39.653.0% of flowCommon StockSEC:0001415889-17-000308:1
- 87,128 shares@ US$19.6116.3% of flowCommon StockSEC:0001415889-17-000282:0
- 89,088 shares@ US$39.6933.7% of flowCommon StockSEC:0001415889-17-000282:1
- 1,700 shares@ US$19.610.3% of flowCommon StockSEC:0001415889-17-000282:2
- 1,700 shares@ US$39.650.6% of flowCommon StockSEC:0001415889-17-000282:3
- 17,421 shares@ US$19.613.3% of flowCommon StockSEC:0001415889-17-000282:4
- 19,687 shares@ US$27.205.1% of flowCommon StockSEC:0001415889-17-000282:5
- 29,644 shares@ US$34.459.7% of flowCommon StockSEC:0001415889-17-000282:6
- 66,752 shares@ US$39.8825.4% of flowCommon StockSEC:0001415889-17-000282:7
10 of 10 declarations
